Polysaccharide hydrogels for regenerative medicine applications
Authors:
- Jacob A. SimsonJSJacob A. Simson
- Jennifer H. ElisseeffJEJennifer H. Elisseeff
- 24 July 2014
- book chapter
- Published by Cambridge University Press (CUP)
- p. 247-262
Abstract
Introduction This chapter begins by reviewing the structure and origin of polysaccharides commonly used in hydrogels and then moves on to a brief discussion of the role of structural polysaccharides throughout tissues in the body. Common chemical modification techniques are discussed, followed by approaches used to crosslink polysaccharides into insoluble hydrogels. The authors will also describe recent research approaches for polysaccharide hydrogel materials as scaffolds for tissue engineering, vehicles for drug delivery, and tissue adhesives. The goal of this chapter is to provide the reader with an overview of the exciting potential of polysaccharide-based hydrogels in medicine. Structure and origin of common polysaccharides Polysaccharides are large linear or branched carbohydrate molecules composed of repeating monomer units. They can perform structurally, as in the extracellular matrix of animals and cell walls of plants [1], or provide energy storage capacity in the instances of glycogen and starch [2]. Every organism on the planet has the ability to produce polysaccharides. Solubilities of polysaccharides in water vary depending on the chemical structure [3]. Monomer units often contain chemical groups that can be functionalized chemically in order to modify their material properties. Important structural polysaccharides in the human body are known as glycosaminoglycans (GAGs), which are anionic, linear polysaccharides composed of repeating disaccharide units. The repeat unit is comprised of a hexosamine and either a hexose or hexuronic acid.Keywords
This publication has 116 references indexed in Scilit:
- Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogelsJournal of Controlled Release, 2011
- The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-βBiomaterials, 2011
- An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defectsBiomaterials, 2011
- A versatile pH sensitive chondroitin sulfate–PEG tissue adhesive and hydrogelBiomaterials, 2010
- Injectable tissue‐engineered bone repair of a rat calvarial defectThe Laryngoscope, 2010
- Polysaccharide‐modified synthetic polymeric biomaterialsPeptide Science, 2010
- Dynamic loading stimulates chondrocyte biosynthesis when encapsulated in charged hydrogels prepared from poly(ethylene glycol) and chondroitin sulfateMatrix Biology, 2010
- Injectable in situ forming biodegradable chitosan–hyaluronic acid based hydrogels for cartilage tissue engineeringBiomaterials, 2009
- Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regenerationActa Biomaterialia, 2009
- Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cellsProceedings of the National Academy of Sciences, 2007